San Francisco, CA, United States of America

Alshad Lalani

This inventor holds 1 USPTO granted patent. Top assignee: Cell Genesys, Inc.. Active years: 2007.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alshad Lalani: Innovator in Cancer Treatment

Introduction

Alshad Lalani is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of cancer treatment through his innovative approaches. His work focuses on the development of therapeutic methods that utilize vector-mediated delivery systems.

Latest Patents

Alshad Lalani holds a patent titled "Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes." This invention provides therapeutic compositions and methods for the vector-mediated delivery and in vivo expression of polynucleotides encoding anti-cancer compounds. The invention particularly emphasizes the use of recombinant viral and non-viral vectors to deliver genes that encode anti-angiogenic or pro-apoptotic gene products for effective cancer treatment. He has 1 patent to his name.

Career Highlights

Lalani is associated with Cell Genesys, Inc., where he continues to advance his research and development efforts. His work has the potential to significantly impact cancer therapies and improve patient outcomes.

Collaborations

Some of his notable coworkers include Thomas Harding and Karin Ute Jooss, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Alshad Lalani's innovative work in cancer treatment exemplifies the importance of research and development in the medical field. His contributions through patenting novel methods highlight the ongoing efforts to combat cancer effectively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…